Concept information
...
Monoclonal antibody preparation
Fremanezumab-containing product
Fremanezumab-containing product in parenteral dose form
Product containing only fremanezumab in parenteral dose form (medicinal product form)
...
Calcitonin gene-related peptide receptor antagonist-containing product
Fremanezumab-containing product
Fremanezumab-containing product in parenteral dose form
Product containing only fremanezumab in parenteral dose form (medicinal product form)
...
Medicinal product categorised by therapeutic role
Medicinal product acting as antimigraine agent (product)
Fremanezumab-containing product in parenteral dose form
Product containing only fremanezumab in parenteral dose form (medicinal product form)
Preferred term
Product containing precisely fremanezumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Broader concept
Has basis of strength substance
Has concentration strength denominator unit
Has concentration strength numerator unit
Has manufactured dose form
Has precise active ingredient
Plays role
In other languages
URI
http://www.irandoc.acir/onto/irandoc/1149558007
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}